Research from Dana-Farber Cancer Institute looks at what happens before the emergence of mutations that interrupt cellular differentiation in colorectal cancer and finds not only evidence of fetal reprogramming that can initiate cancer, but also a protein, Sox9, that fuels that reprogramming.
Sox9 Protein Triggers Colorectal Cancer Time Travel miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Grant Awarded to Explore Hopeful New Treatment Strategies for Gastric and Esophageal Cancers
News provided by
Share this article
Share this article
NEW YORK, March 2, 2021 /PRNewswire/ The DeGregorio Family Foundation, with funding support from the Price Family Foundation and the Esophageal Cancer Awareness Association, has awarded $200,000 to Dr. Nilay Sethi, Principal Investigator at Dana-Farber Cancer Institute.
Dr. Nilay Sethi, Dana-Farber Cancer Institute
Dr. Sethi is a physician-scientist who seeks to generate opportunities for impactful translational advances. His passion for investigative research is fundamentally dependent upon its power to generate a deeper understanding of human disease and in turn to ultimately improve patient care by developing new strategies to prevent and treat cancer.